Related by context. All words. (Click for frequent words.) 73 colorectal adenoma 70 recurrent venous thromboembolism 69 postoperative AF 69 subclinical atherosclerosis 68 PLX STROKE targeting 68 coronary calcification 68 autonomic dysfunction 68 obesity insulin resistance 68 macrovascular disease 68 systolic hypertension 68 carotid IMT 68 abdominal adiposity 68 cardiac conduction 68 insulin resistance syndrome 67 hypertension diabetes mellitus 67 Sleep disturbances 67 elevated triglyceride levels 67 CVD mortality 67 Erythropoietic therapies may 67 arterial calcification 67 microvascular disease 67 gallstone disease 67 Magnesium deficiency 67 postoperative delirium 67 subclinical hypothyroidism 67 metabolic syndrome MetS 67 Heavy snorers 67 chronic thromboembolic pulmonary 67 postoperative atrial fibrillation 67 Severe hypoglycemia 67 serum parathyroid hormone 67 nonalcoholic steatohepatitis 67 obstructive coronary 67 abnormal lipids 67 cardiovascular disease hypertension 66 oesophageal adenocarcinoma 66 impaired glucose metabolism 66 dysglycemia 66 Genetic variants 66 hyperhomocysteinemia 66 insulin resistance precursor 66 Skin sterol 66 extrapyramidal symptoms 66 intracranial stenosis 66 thromboembolic disease 66 Aortic stenosis 66 Alzheimer Disease AD 66 persistent pulmonary hypertension 66 Tasigna prolongs 66 CP CPPS 66 endometrial hyperplasia 66 gastro oesophageal reflux 66 atherothrombosis 66 embolic stroke 66 thromboembolic 66 hypercholesterolaemia 66 Atherosclerotic 66 carotid plaques 66 vascular inflammation 66 Darapladib 66 intima media thickness 65 atherogenesis 65 Diabetic neuropathy 65 untreated OSA 65 thyrotropin levels 65 atherosclerotic disease 65 Statin therapy 65 Chronic pancreatitis 65 symptomatic VTE 65 SRBD 65 prolonged QT interval 65 hereditary predisposition 65 proliferative retinopathy 65 syndrome OSAS 65 silent ischemia 65 perimenopausal women 65 breast endometrial 65 thyroid dysfunction 65 neurodevelopmental outcome 65 diabetic kidney 65 neurocognitive deficits 65 nonfasting triglycerides 65 left ventricular dysfunction 65 artery stenosis 65 Myocardial infarction 65 Depressive symptoms 65 gastro esophageal reflux 65 intermittent hypoxia 65 glycated hemoglobin levels 65 postoperative mortality 65 cerebral infarction 65 metabolic disturbances 65 variant angina 65 proliferative diabetic retinopathy 65 Colon polyps 65 hyperglycaemia 65 depressive symptomatology 65 arterial stiffening 65 Cholesterol Levels SPARCL 65 myocardial ischemia 65 type2 diabetes 65 cortisol secretion 65 carotid stenosis 65 impaired insulin secretion 65 prostate cancer CaP 65 cerebral vasospasm 65 LV dysfunction 65 perfusion defects 65 comorbid depression 65 STRIDE PD 65 predisposing factor 64 elevated CRP 64 thrombo embolic 64 Uncontrolled hypertension 64 Pulmonary hypertension 64 venous thromboembolic disease 64 subclinical hyperthyroidism 64 Hypotension 64 induced ischemia 64 hyperparathyroidism 64 untreated hypothyroidism 64 subclinical inflammation 64 Endothelial dysfunction 64 cardiac dysfunction 64 Excessive daytime sleepiness 64 coronary artery atherosclerosis 64 hemorrhagic complications 64 VADT 64 recurrent VTE 64 adenomatous 64 unmeasured confounders 64 flow mediated dilation 64 nonfasting triglyceride levels 64 Obstructive sleep apnea 64 pressure natriuresis 64 Peripheral arterial disease 64 parkinsonism 64 serum estradiol 64 remnant lipoproteins 64 hypovitaminosis D 64 multifactorial disease 64 cartilage degeneration 64 Genetic predisposition 64 microvascular complications 64 ventricular tachyarrhythmia 64 GBA mutations 64 recurrent DVT 64 adiponectin levels 64 atherosclerotic lesions 64 aortic stiffness 64 torsade de pointes 64 salivary cortisol 64 postoperative pulmonary 64 Lp PLA 2 64 plasma triglycerides 64 Multiethnic Study 64 improves insulin sensitivity 64 reflux disease 64 Singh Manoux 64 plasma lipid 64 nonalcoholic steatohepatitis NASH 64 Endothelial function 64 neurodevelopmental outcomes 64 macrovascular events 64 airway hyperresponsiveness 64 monogenic 64 intracranial atherosclerosis 64 artery calcification 64 vascular dysfunction 64 left ventricular diastolic 64 Proteinuria 64 ovarian hormones 63 colorectal adenomas 63 arterial thickening 63 Chronic insomnia 63 lipid abnormalities 63 vascular reactivity 63 overt nephropathy 63 Sleep disordered breathing 63 repolarization 63 progressive neurodegenerative disorder 63 arterial inflammation 63 untreated sleep apnea 63 diabetes mellitus DM 63 intravascular hemolysis 63 CETP inhibition 63 elevated LDL cholesterol 63 Daytime sleepiness 63 elevated triglycerides 63 metabolic abnormality 63 liver metastasis 63 gastric cardia 63 esophageal squamous cell carcinoma 63 dysrhythmias 63 thyrotoxicosis 63 Secondhand smoke exposure 63 nulliparous women 63 cerebrovascular events 63 electroencephalographic 63 airflow limitation 63 daytime drowsiness 63 chorioamnionitis 63 Ischemic 63 abnormal lipid 63 Coronary artery calcification 63 Untreated sleep apnea 63 cardioembolic stroke 63 frequent awakenings 63 prostate carcinogenesis 63 acetabular dysplasia 63 HIV HCV coinfected 63 polyp recurrence 63 symptomatic intracranial 63 HER2 expression 63 myeloperoxidase 63 impaired cognition 63 antioxidant supplementation 63 complement inhibitor eculizumab 63 inflammatory biomarkers 63 perioperative morbidity 63 neuropsychiatric symptoms 63 T1DM 63 metabolic abnormalities 63 metabolic dysfunction 63 atherogenic dyslipidemia 63 prothrombotic 63 aneurysmal subarachnoid hemorrhage 63 spirometric 63 Venous thromboembolism 63 diabetic microvascular complications 63 angiographically 63 impair fertility 63 metabolic syndromes 63 Thromboembolism 63 bronchopulmonary dysplasia 63 familial hypercholesterolemia FH 63 coronary blockages 63 androgen suppression 63 multi factorial disease 63 prefrontal cortical 63 ABCB1 63 thyroid hormone levels 63 QTc prolongation 63 mixed hyperlipidemia 63 aortic atherosclerosis 63 arterial stiffness 63 rhythm disturbances 63 Hypertriglyceridemia 63 potentially modifiable 63 urate levels 63 leiomyomas 63 syncope fainting 63 amino acid homocysteine 63 hyperinsulinemia 63 residual confounding 63 overactive bladder symptoms 63 cortical thinning 63 atherothrombotic disease 63 utero exposure 63 atopic disease 63 bronchopulmonary dysplasia BPD 63 Eisenmenger syndrome 63 amyloid deposition 63 coronary artery calcification 63 endometrial carcinoma 63 obstructive coronary artery 63 myocardial infarction MI 63 hypokalemia hypomagnesemia 63 nonfatal MI 63 glucocorticoid hormones 63 elevated cortisol 63 electron beam computed tomography 63 intensive statin therapy 63 genetic polymorphisms 63 Subarachnoid hemorrhage 63 multi infarct dementia 63 prostate cancer PCa 63 Ischemic heart 62 Diabetic nephropathy 62 fasting glucose levels 62 bronchial hyperresponsiveness 62 carotid artery blockage 62 knee osteoarthritis OA 62 inflammatory rheumatic 62 shorter telomere length 62 Postmenopausal hormone therapy 62 Heavy menstrual bleeding 62 rCBF 62 thromboembolic complications 62 abnormal lipid levels 62 elevated homocysteine 62 Folate deficiency 62 serum homocysteine 62 artherosclerosis 62 airway constriction 62 oral antidiabetic medication 62 beta blocker therapy 62 serum leptin 62 primary hyperparathyroidism 62 abnormal glucose tolerance 62 thrombophilia 62 hypoperfusion 62 cerebrovascular diseases 62 chronic periodontitis 62 torsades de pointes 62 GH deficiency 62 recurrent atrial fibrillation 62 fibrosis scarring 62 Prostatitis 62 Hypertrophy 62 MetS 62 autoimmune thyroid 62 heart arrhythmias 62 atherosclerosis plaque buildup 62 thrombotic complications 62 bilateral oophorectomy 62 IDDM 62 neurocognitive impairment 62 obstructive airway disease 62 cerebral microbleeds 62 β blockers 62 visceral adiposity 62 computed tomography angiography 62 membranous nephritis 62 intima media thickness IMT 62 Microalbuminuria 62 Cardiac hypertrophy 62 recurrent miscarriage 62 chromium supplementation 62 OSAHS 62 distal colon cancer 62 multivariate adjustment 62 beta carotene supplementation 62 Hyperparathyroidism 62 Subgroup analyzes 62 alexithymia 62 Ventricular Tachycardia 62 gastro esophageal reflux disease 62 Nocturia 62 cardio metabolic 62 CARDIA study 62 Fatty liver 62 dermatologic reactions 62 macrovascular 62 underactive thyroid gland 62 intracranial hypertension 62 myoclonus 62 antiphospholipid syndrome 62 Restless legs 62 apolipoprotein E4 62 serum lipids 62 atherosclerosis narrowing 62 chronic prostatitis 62 bicuspid aortic valves 62 Chemotherapy induced 62 platelet activation 62 valvular disease 62 de ath 62 Carotid Revascularization Endarterectomy vs. 62 nasopharyngitis headache 62 endothelial dysfunction 62 soluble CD# ligand 62 brain lesions 62 estrogen deficiency 62 ventricular remodeling 62 capillary leakage 62 CHD CVD 62 claudication 62 glucose abnormalities 62 carotid plaque 62 clinically insignificant 62 ADPKD 62 advanced adenoma 62 valvular heart disease 62 Irregular heartbeat 62 reinfarction 62 transfusion syndrome 62 TCF#L# gene 62 pathophysiological mechanisms 62 habitual snoring 62 angina chest 62 silent myocardial ischemia 62 C Reactive Protein 62 premenstrual syndrome PMS 62 EBV infection 62 hematopoietic cancers 62 aminotransferase ALT 62 Cognitive impairment 62 ischemic stroke 62 etiologic 62 distensibility 62 circadian rhythm disorders 62 microbleeds 62 carotid bruit 62 nonmelanoma skin cancers 62 modifiable risk 62 fasting insulin 62 leukocyte counts 62 Arrhythmias 62 neuronal dysfunction 62 echocardiographic parameters 62 obstructive sleep 62 fibrin deposition 62 white matter hyperintensities 62 serum phosphate 62 abnormal glucose metabolism 62 atherothrombotic 62 hyperphenylalaninemia HPA due 62 Obstructive sleep apnea OSA 62 parkinsonian symptoms 62 abnormal vaginal bleeding 62 lichen planus 62 endometriosis ovarian cysts 62 Idiopathic 62 APOE genotype 62 prolactin elevation 62 gestational hypertension 62 albumin excretion rate 62 debilitating complication 61 Renal dysfunction 61 untreated celiac disease 61 carotid artery ultrasound 61 onset diabetes mellitus 61 metabolic acidosis 61 acute myocardial infarction MI 61 Pulmonary Embolism PE 61 ventricular arrhythmia 61 Wernicke encephalopathy 61 Lowering cholesterol 61 hypoglycemic episodes 61 squamous cell lung cancer 61 experimentally induced 61 dietary DHA 61 Chlamydia trachomatis infection 61 Alzheimer disease vascular dementia 61 normotensive 61 chronic hepatitis cirrhosis 61 serum BDNF 61 overt hypothyroidism 61 elevated IOP 61 urothelial cancer 61 colorectal neoplasms 61 hepatocellular carcinoma liver 61 plasma lipids 61 arteries atherosclerosis 61 Zinc deficiency 61 statins cholesterol lowering 61 juvenile idiopathic arthritis JIA 61 intracerebral haemorrhage 61 airflow obstruction 61 disordered breathing 61 dopaminergic therapy 61 Hypertrophic cardiomyopathy 61 inversely associated 61 Mitral regurgitation 61 precancerous tumors 61 coronary artery calcium 61 polycystic ovary syndrome PCOS 61 GRNCM1 61 renal scarring 61 severe hypoglycaemia 61 noncardiovascular mortality 61 Subgroup analysis 61 folate deficiency 61 urolithiasis 61 SIADH 61 preserved ejection fraction 61 colorectal neoplasia 61 thyrotropin 61 prenatal exposures 61 atherosclerosis 61 Hemorrhagic stroke 61 plasma homocysteine 61 #ß HSD1 61 Exacerbation 61 triacylglycerol concentrations 61 haemorrhagic stroke 61 hypoxemia 61 hypocalcaemia 61 IUGR 61 atrial arrhythmias 61 comorbid disorders 61 cardiac repolarization 61 Postmenopausal 61 HNSCC 61 aminotransferases 61 serum urate levels 61 Coronary artery calcium 61 gallbladder disease 61 apneic episodes 61 Subclinical 61 Soy isoflavones 61 artery elasticity 61 serum GGT 61 decompensated heart failure 61 Urinary tract 61 EEG abnormalities 61 NAFLD 61 variceal bleeding 61 systolic dysfunction 61 stratifying patients 61 cardiovascular disease 61 seizures comas 61 neurological degeneration 61 transferrin saturation 61 HeFH 61 leptin deficiency 61 myopathy rhabdomyolysis 61 non cirrhotic portal 61 asthma rhinitis 61 noncardiac surgery 61 INTERHEART study 61 cardiorespiratory fitness 61 Torsades de Pointes 61 Nonalcoholic Fatty Liver Disease 61 deCODE Glaucoma TM 61 abnormal heartbeats 61 familial clustering 61 Genetic mutation 61 cardiovascular mortality 61 androgen deficiency 61 intracerebral hemorrhage 61 pulmonary toxicity 61 nephrolithiasis 61 facial clefts 61 narcolepsy cataplexy 61 cerebral ischemia 61 juvenile idiopathic arthritis 61 Parkinson disease PD 61 antenatal depression 61 deep vein thromboses 61 untreated obstructive sleep 61 Chronic angina 61 primary aldosteronism 61 Vitamin D insufficiency 61 spontaneous regression 61 Radical prostatectomy 61 atrial tachyarrhythmias 61 androgen excess 61 colorectal carcinoma 61 cardiovascular morbidity 61 gastric carcinoma 61 upper gastrointestinal bleeding 61 CYT# potent vascular disrupting 61 atypical neuroleptics 61 primidone 61 Wisconsin Sleep Cohort 61 neurocognitive function 61 albumin excretion 61 evaluate ZFP Therapeutic 61 Diabetes Interventions 61 related maculopathy 61 postmenopausal hormone replacement 61 anovulation 61 albuminuria 61 growth hormone secretion 61 cerebral oxygenation 61 hyperprolactinemia 61 AA Amyloidosis 61 hippocampal atrophy 61 postmenopausal estrogen 61 vasomotor symptoms 61 atherosclerotic coronary 61 glutamate neurotransmission 61 pretest probability 61 thrombocytopenic 61 Albuminuria 61 intestinal motility 61 catheter angiography 61 vestibular dysfunction 61 left ventricular hypertrophy 61 NIASPAN 61 Cholangiocarcinoma 61 postmenopausal breast cancer 61 glucocorticoid therapy 61 noncardiac 61 DQB1 * 61 PAOD 61 obese postmenopausal 61 Enlarged prostate 61 neurologic complications 61 arterial stenosis 61 bacteriuria 61 Generalized anxiety disorder 61 HMG CoA reductase inhibitors 61 atheromatous 61 CTEPH 61 idiopathic pulmonary arterial hypertension 61 CC genotype 61 #q# deletion 61 undergoing radical prostatectomy 61 lipoprotein metabolism 61 dyslipidaemia 61 plasminogen activators 61 serum uric acid 61 hyperacute 61 inappropriate antidiuretic hormone SIADH 61 Premature menopause 61 Vitamin D supplementation 61 Acute pancreatitis 61 serum selenium 61 Irritable Bowel 61 Impaired glucose tolerance 61 cardiovascular disease osteoporosis 61 Complications Trial 61 androgen ablation 61 corrected QT interval 61 LRP5 61 intraventricular hemorrhage 61 colorectal polyps 61 MTHFD1L gene 61 acute aortic dissection 61 central adiposity 61 basal cell nevus syndrome 61 Coronary artery bypass graft 61 comorbid anxiety 61 root caries 61 knee OA 61 neuritic 61 plasma selenium 61 vitreous floaters 61 multivariate logistic regression 61 intra abdominal abscess 61 Computerized tomography 61 #F FDG PET 61 androgen depletion therapy 61 Bruxism 61 triiodothyronine 61 lowering triglyceride levels 61 Mood disorders 61 antiplatelet therapies 61 rate variability HRV 61 MS relapses 61 PON1 activity 61 kidney urologic 61 arteriography 60 Hyperlipidemia 60 diastolic hypertension 60 calcium antagonists 60 thiazide 60 carbohydrate intolerance 60 obstructive sleep apnea 60 Estrogen deficiency 60 Uterine cancer 60 elevated fasting glucose 60 glycosylated hemoglobin HbA1c 60 troponin T 60 olfactory dysfunction 60 spiral computed tomography 60 transient elastography 60 induce orthostatic hypotension 60 testicular tumors 60 diabetes hyperlipidemia 60 probiotic supplementation 60 chronic pancreatitis 60 tachyarrhythmias 60 Binge eating 60 insomnia somnolence 60 hepatic fibrosis 60 Maternal obesity 60 electrophysiologic 60 hypercalcaemia 60 Brodmann Area 60 elevated uric acid 60 leukotriene pathway 60 inhaled budesonide 60 sensory disturbances 60 bullous 60 vitamin D inadequacy 60 Vigorous exercise 60 lymphomas leukemias 60 postoperative morbidity 60 transcranial Doppler ultrasound 60 prospective multicentre 60 elevated serum creatinine 60 glycemia 60 coinfection 60 multivariable analysis 60 metabolic parameters 60 receptor inhibitor 60 Premenopausal women 60 myocardial contractility 60 euthymic patients 60 KCNH2 60 Hypoglycaemia 60 headache nasopharyngitis 60 thromboembolism 60 arrhythmogenic 60 obesity sedentary lifestyle 60 PIGF 60 hepatocellular 60 tibolone 60 progressive dyspnea 60 tau protein tangles 60 glial tumors 60 hypothalamic pituitary adrenal axis 60 APOE e4 60 nausea constipation 60 undergoing coronary angiography 60 da mage 60 myocardial dysfunction 60 diabetes dyslipidemia 60 cerebral vascular disease 60 CHD coronary 60 breast cancer metastasis 60 hyperammonemia 60 renal dysfunction 60 familial hypercholesterolemia 60 Osteoarthritis OA 60 Parkinson Disease PD 60 cardio vascular disease 60 loop diuretics 60 dopamine antagonists 60 Observational studies 60 idiopathic pulmonary 60 intestinal polyps 60 nonfatal myocardial infarction MI 60 gastric carcinogenesis 60 gastrointestinal GI bleeding 60 mania hypomania 60 Avandia Actos 60 menstrual irregularity 60 anterior temporal 60 neurologic symptoms 60 lobular breast cancer 60 Inhaled nitric oxide 60 obstructive pulmonary disease 60 cirrhosis liver failure 60 PM#.# exposure 60 Elevated cholesterol 60 pathological hallmark 60 atrophic gastritis 60 QTc interval 60 Electrophysiological 60 clinically meaningful reductions 60 DHEA supplementation 60 cardiac troponin 60 Non Alcoholic Fatty 60 ischemic vascular 60 neural degeneration 60 hippocampal volume 60 atherosclerotic cardiovascular 60 genetic determinants 60 histologic subtype 60 urate lowering 60 renal artery stenosis 60 Hypercholesterolemia 60 secondary hyperparathyroidism 60 serum lipid levels 60 patients undergoing CABG 60 nonseminoma 60 thromboembolic events 60 anticoagulant warfarin 60 hepatotoxicity 60 adenoma recurrence 60 E selectin 60 infective endocarditis 60 Hashimoto thyroiditis 60 ALB # 60 menstrual dysfunction 60 lipoprotein Lp 60 Parathyroid hormone 60 plasma homocysteine levels 60 neonatal morbidity 60 MGUS 60 isoflavone supplement 60 receiving VELCADE 60 serum cortisol 60 nonvertebral fracture 60 dietary acrylamide 60 aortic valve stenosis 60 incidentalomas 60 glucose intolerance 60 liver steatosis 60 androgen deprivation 60 selective modulator 60 coronary stenosis 60 urinary symptoms 60 abdominal girth 60 serum phosphorous 60 perioperative complications 60 BYSTOLIC 60 plasma kallikrein 60 testosterone supplementation 60 coronary arterial 60 causal pathway 60 postmenopausal hormone 60 atherosclerotic lesion 60 CHD mortality 60 Duodenal 60 obstructive sleep apnea hypopnea 60 Atrial fibrillation AF 60 disease NAFLD 60 mammographic density 60 AML MDS 60 metabolic syndrome clustering 60 sleep disordered breathing 60 Lp PLA2 60 Restless Legs Syndrome RLS 60 authors hypothesize 60 induced cardiomyopathy 60 antiphospholipid antibodies 60 pathophysiologic 60 deCODE AF TM 60 liver scarring 60 creatine supplementation 60 coagulopathy 60 Comorbid 60 PLMS 60 neurofibrillary 60 subclinical disease 60 bacterial prostatitis 60 Prehypertension 60 ipsilateral stroke 60 carotid intima media 60 Low density lipoprotein 60 PLMs 60 Cardiotoxicity 60 HER2 overexpression 60 autoantibody levels 60 Helicobacter pylori infection 60 metachronous 60 Hydroxyurea 60 acid suppressive medications 60 perioperatively 60 reflux symptoms 60 severe mitral regurgitation 60 psychosocial variables 60 renal insufficiency 60 psychiatric morbidity 60 Nonalcoholic fatty liver 60 Iron deficiency anemia 60 coronary artery disease 60 hypertension hypercholesterolemia 60 susceptibility locus 60 pleiotropic effects 60 pulmonary arterial 60 SGPT 60 diabetes mellitus T2DM 60 trial evaluating PRX# 60 Carotid endarterectomy 60 Lipoprotein 60 neuropsychiatric diseases 60 atherosclerotic cardiovascular disease 60 ductal carcinomas 60 dietary modification 60 mitochondrial toxicity 60 Hepatotoxicity 60 depression suicidal ideation 60 Bacterial vaginosis 60 Hormone pills 60 carotid artery stenting CAS 60 adenotonsillectomy 60 allogeneic HSCT 60 lactate dehydrogenase LDH 60 Angiograms carry slight 60 atherosclerosis hardening 60 tic severity 60 nonischemic 60 intact parathyroid hormone 60 psoriatic arthritis PsA 60 MIRAPEX ER 60 endocrinologic 60 airway hyper responsiveness 60 PHPT 60 fructose intake 60 serum lipid 60 severe periodontitis 60 Homocysteine 60 antiarrhythmic drug 60 reproductive abnormalities 60 nocturnal hypoglycemia 60 Osteopenia 60 coronary disease 60 SE alleles 60 generalized seizures 60 Homocysteine levels 60 CYP#D# inhibitor 60 morphometric vertebral fractures 60 myocardial fibrosis 60 calcium supplementation 60 Catheter Associated 60 coronary atherosclerosis 60 Unstable angina 60 precancerous colon polyps 60 calcified plaques 60 fetal chromosomal 60 perinatal morbidity 60 CSF biomarkers 60 deep venous thromboses 60 maintaining cardiorespiratory fitness 60 thiazide diuretics 59 carotid artery thickness 59 superior mesenteric artery 59 PIK3CA 59 Strenuous exercise 59 vertigo dizziness 59 lowering blood glucose 59 radiographic progression 59 endocrine abnormalities 59 post thrombotic syndrome 59 Brugada syndrome 59 Apolipoprotein B 59 Ovary removal 59 bezafibrate 59 infarcts 59 leptin deficient mice 59 carotid artery stenosis 59 clomipramine 59 elevated ALT 59 truncal 59 Epileptic seizures 59 AGILECT R 59 cognitive dysfunctions 59 Thyroid disorders 59 paroxysmal AF 59 bladder dysfunction 59 rs# [002] 59 dietary calcium intake 59 macroalbuminuria 59 chromosome #q#.# deletion 59 Esophagitis 59 Calcium vitamin D 59 anti arrhythmic drug 59 Abdominal aortic aneurysms 59 cognitive dysfunction 59 haematologic 59 multivariable adjusted 59 longitudinal cohort study 59 hypercalciuria 59 Moderate drinkers 59 bowel polyps 59 paraneoplastic 59 adrenal function 59 cTnT 59 oncogenic HPV 59 thyroid tumors 59 pulmonary hypertension PH 59 hepatic cirrhosis 59 non valvular atrial 59 phytoestrogen intake 59 abstinent alcoholics 59 disc degeneration 59 FGFR2 gene 59 orofacial clefts 59 lung metastasis 59 neovascularisation 59 Oxidative damage 59 anticoagulants blood thinners 59 nonfatal stroke 59 menstrual abnormalities 59 inflammatory polyarthritis 59 nonalcoholic fatty liver 59 percutaneous interventions 59 Nonspecific 59 QT prolongation 59 EXJADE 59 akinesia 59 Polycystic ovary syndrome PCOS 59 nonsevere 59 hyperalgesia 59 prospective multicenter study 59 amenorrhoea 59 microalbuminuria 59 exhaled nitric oxide 59 Arterial stiffness 59 tumor histology 59 circulating estrogens 59 FeNO 59 nondiabetics 59 lowering homocysteine 59 serum calcium 59 occlusive disease 59 serum vitamin D 59 postoperative complication 59 hypervascular tumors 59 overt hepatic encephalopathy HE 59 ATACAND 59 Menopausal hormone therapy 59 Angiotensin converting enzyme 59 gynecologic malignancy 59 hormonal abnormalities 59 chlamydial infection 59 carcinoid tumor 59 gastrointestinal reflux 59 chronic renal insufficiency 59 prognostic significance 59 motor neuron degeneration 59 Pulmonary embolism 59 syncopal 59 Hutchinson Gilford progeria 59 hyperlipidemia hypertension 59 hemodynamic instability 59 interstitial lung abnormalities 59 endothelial activation 59 corticosteroid induced 59 postoperative complications 59 polycystic ovarian syndrome PCOS 59 gross hematuria